These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 31010865

  • 21. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
    Li Y, Huang J, Li L, Liu L.
    Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
    [Abstract] [Full Text] [Related]

  • 22. Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa In Vitro and In Vivo.
    Moustafa DA, Wu AW, Zamora D, Daly SM, Sturge CR, Pybus C, Geller BL, Goldberg JB, Greenberg DE.
    mBio; 2021 Jan 12; 12(1):. PubMed ID: 33436433
    [Abstract] [Full Text] [Related]

  • 23. Integron types, antimicrobial resistance genes, virulence gene profile, alginate production and biofilm formation in Iranian cystic fibrosis Pseudomonas aeruginosa isolates.
    Pournajaf A, Razavi S, Irajian G, Ardebili A, Erfani Y, Solgi S, Yaghoubi S, Rasaeian A, Yahyapour Y, Kafshgari R, Shoja S, Rajabnia R.
    Infez Med; 2018 Sep 01; 26(3):226-236. PubMed ID: 30246765
    [Abstract] [Full Text] [Related]

  • 24. Effect of L-arginine on cystic fibrosis Pseudomonas aeruginosa biofilms.
    Eisha S, Morris AJ, Martin I, Yau YCW, Grasemann H, Waters V.
    Antimicrob Agents Chemother; 2024 Aug 07; 68(8):e0033624. PubMed ID: 39023260
    [Abstract] [Full Text] [Related]

  • 25. Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.
    Plasencia V, Borrell N, Maciá MD, Moya B, Pérez JL, Oliver A.
    Antimicrob Agents Chemother; 2007 Jul 07; 51(7):2574-81. PubMed ID: 17470655
    [Abstract] [Full Text] [Related]

  • 26. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice.
    Hoffmann N, Lee B, Hentzer M, Rasmussen TB, Song Z, Johansen HK, Givskov M, Høiby N.
    Antimicrob Agents Chemother; 2007 Oct 07; 51(10):3677-87. PubMed ID: 17620382
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
    Field TR, White A, Elborn JS, Tunney MM.
    Eur J Clin Microbiol Infect Dis; 2005 Oct 07; 24(10):677-87. PubMed ID: 16249934
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Tré-Hardy M, Traore H, El Manssouri N, Vanderbist F, Vaneechoutte M, Devleeschouwer MJ.
    Int J Antimicrob Agents; 2009 Oct 07; 34(4):370-4. PubMed ID: 19505804
    [Abstract] [Full Text] [Related]

  • 32. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
    Price KE, Orazi G, Ruoff KL, Hebert WP, O'Toole GA, Mastoridis P.
    PLoS One; 2015 Oct 07; 10(10):e0141192. PubMed ID: 26506004
    [Abstract] [Full Text] [Related]

  • 33. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D, Rose B, Pajkos A, Robinson M, Bye P, Bell S, Elkins M, Thompson B, Macleod C, Aaron SD, Harbour C.
    J Clin Microbiol; 2005 Oct 07; 43(10):5085-90. PubMed ID: 16207967
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin.
    Halwani M, Blomme S, Suntres ZE, Alipour M, Azghani AO, Kumar A, Omri A.
    Int J Pharm; 2008 Jun 24; 358(1-2):278-84. PubMed ID: 18448284
    [Abstract] [Full Text] [Related]

  • 38. Effect of pH on the antimicrobial susceptibility of planktonic and biofilm-grown clinical Pseudomonas aeruginosa isolates.
    Moriarty TF, Elborn JS, Tunney MM.
    Br J Biomed Sci; 2007 Jun 24; 64(3):101-4. PubMed ID: 17910277
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.